Bilkent UNAM Presents: Advanced Cancer Biotherapeutics Symposium (ACTS ’24) — Pioneering Innovations in Cancer Treatment
Bilkent University UNAM (National Nanotechnology Research Center) is delighted to announce the Advanced Cancer Biotherapeutics Symposium (ACTS ’24) scheduled to take place on October 4-5, 2024. This symposium will bring together clinicians, academics, graduate students and industry partners to explore cutting-edge technologies and therapies in cancer treatment.
ACTS ’24 marks the beginning of an annual platform for sharing knowledge and fostering collaborations in the field of cancer biotherapeutics. This inaugural event brings together leading experts to discuss the latest advancements in cancer treatment and to set the stage for future gatherings dedicated to this vital area of research.
Prof. Roman Jerala from the National Institute of Chemistry in Slovenia will share his expertise in cellular therapies and offer insight into the latest advancements in synthetic biology and immunology.
Prof. Fatih Ezgü from Gazi University’s Faculty of Medicine will present groundbreaking research on gene and cellular therapies.
Prof. Tarkan Karakan from Gazi University’s Faculty of Medicine will share his insights into gastroenterology and its implications for cancer treatment.
Prof. Tunca Doğan from Hacettepe University will present bioinformatic approaches in cancer treatment, focusing on computational strategies to advance therapeutic development.
Assoc. Prof. Sibel Kalyoncu from the Izmir Biomedicine and Genome Center (IBG) will discuss her innovative research in antibody engineering and its potential in cancer therapies.
Assoc. Prof. Li Tang from the Institute of Bioengineering at École Polytechnique Fédérale de Lausanne will delve into the innovative field of cytokine and antibody engineering.
Assoc. Prof. Tamer Önder from Koç University’s Research Center for Translational Medicine will offer his expertise in cellular therapies and their applications in combating cancer.
Asst. Prof. Urartu Şeker from Bilkent University UNAM will present his cutting-edge work in antibody and cellular engineering, exploring new frontiers in cancer treatment.
The two-day program is packed with keynote lectures, invited talks, lightning presentations, and networking opportunities.
To register: https://acts.unam.bilkent.edu.tr/
